Objective To investigate the clinical features of elderly patients with acute pancreatitis (AP) aged ≥80 years.Methods A retrospective analysis was performed for 3642 patients with pancreatitis who were admitted to Department of Gastroenterology in The Affiliated Hospital of Southwest Medical University from January 2013 to December 2019, and according to age, they were divided into young group (aged < 65 years) with 2955 patients, middle-aged group (aged 65-79 years) with 558 patients, and elderly group (aged ≥80 years) with 129 patients. Related clinical data were collected and analyzed, including sex, age, etiology, predisposing factors, past medical history, disease severity, complication, and clinical outcome. The independent samples one-way ANOVA-test was used for comparison of normally distributed continuous data between groups and the least significant difference t-test was used for comparison within each group; the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between groups; the chi-square test or the Fisher's exact test was used for comparison of categorical data between groups; the Kruskal-Wallis H test was used for comparison of ordinal categorical variables.Results In the young group, there were 1721 male patients and 1234 female patients; in the middle-aged group, there were 214 male patients and 334 female patients; in the elderly group, there were 48 male patients and 81 female patients; the middle-aged group and the elderly group had a significantly higher proportion of female patients than the young group (62.8% vs 61.6% vs 41.8%, P < 0.05). High-fat diet was the main predisposing factor for all three groups, and compared with the young group, the elderly group had a significantly lower proportion of patients with AP induced by alcohol or high-fat diet+alcohol (P < 0.05). The elderly group had a significantly higher proportion of patients with the etiology of biliary diseases than the middle-aged group and the young group (79.8% vs 69.2% vs 41.4%, χ2=204.127, P < 0.05), as well as a significantly lower proportion of patients with the etiology of hyperlipidemia, alcohol, or biliary diseases+hyperlipidemia (all P < 0.05). Among the 129 patients in the elderly group, 83 (64.3%) had mild AP, 23 (17.8%) had moderate-severe AP, and 23 (17.8%) had severe AP; there was a significant difference in the constituent ratio of disease severity between the elderly group and the middle-aged/young groups (H=1972.5, P < 0.05). The elderly group and the middle-aged group had a significantly lower proportion of patients with recurrence than the young group (both P < 0.05). There were no significant differences in local complications between the three groups (all P > 0.05), and as for systemic complications, compared with the young group, the elderly group had a significantly higher proportion of patients with pneumonia (3.9% vs 2.2%, P < 0.05), acute kidney injury (AKI) (6.2% vs 2.5%, P < 0.05), or multiple organ dysfunction syndrome (MODS) (7.8% vs 4.0%, P < 0.05). Compared with the middle-aged group and the young group, the elderly group had a significantly lower proportion of cured patients (67.4% vs 76.3% vs 82.0%, P < 0.05) and a significantly higher proportion of patients with improvement (23.3% vs 14.7%/12.7%, P < 0.05). The elderly group and the middle-aged group had a significantly higher proportion of patients withdrawn from treatment than the young group (8.5%/5.9% vs 3.4%, P < 0.05). There was 1 death in the elderly group (0.8%), 9 deaths in the middle-aged group (1.6%), and 16 deaths in the young group (0.5%), and there was no significant difference between the three groups (P > 0.05). There were no significant differences in length of hospital stay and hospital costs between the three groups (P > 0.05).Conclusion AP patients aged ≥80 years are mainly female and are often caused by biliary factors, and they are likely to develop the complications such as pneumonia, AKI, and MODS.
按照UDCA治疗应答情况，637例患者中436例发生完全应答，201例为应答不良。性别分布中，完全应答组与应答不良组分布无统计学意义(P值均＞0.05)，基线存在肝硬化的患者UDCA应答率更高(78.9% vs 71.1%，P=0.032)，生化指标中，TBil、AST、ALP、TBA和TC在两组间存在统计学差异(P值均＜0.001)。免疫指标中，应答不良组IgA、IgM水平及抗Gp210阳性率均较高(P值均＜0.05)。预后风险评分中，应答不良组MRS、Globe评分、UK-PBC评分均高于完全应答组(P值均＜0.001)(表 2)。
表
2
UDCA治疗完全应答与应答不良患者基线指标及风险评分差异
Table
2.
Differences of baseline characteristics and risk scores between PBC with complete response and poor response to UDCA treatment
根据IgM预测UDCA应答不良的最佳临界值将患者分为IgM≥1.5×ULN及IgM＜1.5×ULN两组，性别分布、年龄、肝硬化占比在两组中比较差异均无统计学意义(P值均＞0.05)；IgM≥1.5×ULN组AST、ALP、TC显著高于IgM＜1.5×ULN组(P值均＜0.05)；IgM≥1.5×ULN组IgG水平及抗Gp210阳性率显著高于IgM＜1.5×ULN组(P值均＜0.001)。IgM≥1.5×ULN组经过UDCA治疗后发生应答不良患者显著高于IgM＜1.5×ULN组(38.3% vs 27.1%，P=0.003)(表 5)。
表
5
不同IgM水平PBC患者基线临床特征及UDCA疗效比较
Table
5.
Comparison of baseline characteristics and the outcome of UDCA treatment between PBC with different levels of IgM
UDCA是PBC治疗的一线药物，可显著改善部分PBC患者非肝移植存活率[11-12]，但仍有30%~40%的患者对UDCA治疗无应答，本研究中显示UDCA完全应答率为68.4%，对于这部分患者需要及时联合一种或两种二线药物来改善胆汁淤积以预防疾病进展[13]。UDCA治疗可能影响IgM水平，研究[14]发现UDCA能够显著降低细菌CpG诱导的总IgM和IgM-AMA的产生，但对IgG-AMA的水平却无影响。IgM与肝硬化相关症状和肝脏相关事件的发生关系密切，在UDCA联合苯扎贝特治疗过程中，不论ALP及GGT下降与否，当IgM水平持续异常时，患者的预后均较差，其生存期显著低于IgM水平正常化的患者，治疗过程中IgM水平的逐步正常化可能提示预后较好[15]。对于UDCA不完全应答的PBC患者，在给予联合利妥昔单抗治疗后，IgM水平随着肝功能指标的好转而逐步下降[16]。IgM正常化可作为长期预后的预测指标，但初始IgM正常患者IgM水平的变化情况及预测因素尚缺乏研究。在本研究中，UDCA治疗基线IgM平均水平为2.76 g/L，IgM升高的占比为56.0%，在UDCA完全应答组与应答不良组之间，基线IgM水平存在显著性差异(P=0.034)，进一步分析IgM升高与IgM正常组患者的临床特征及在UDCA治疗1年后的疗效差异，发现IgM正常组UDCA应答率高于IgM升高组(71.8% vs 65.8%)，但两组差异无统计学意义(P=0.108)，通过ROC曲线分析获得IgM预测UDCA治疗1年后应答不良风险的最佳临界值(1.5×ULN)，按最佳临界值进行分组后，结果显示IgM＜1.5×ULN组的PBC患者发生UDCA应答率显著高于IgM≥1.5×ULN组(72.9% vs 61.7%, P=0.003)，IgM≥1.5×ULN组发生UDCA应答不良风险是前者的1.416倍(95%CI: 1.129~1.776)，因此基线IgM水平可能有助于预测PBC治疗应答。
LEPPÄNIEMI A, TOLONEN M, TARASCONI A, et al. 2019 WSES guidelines for the management of severe acute pancreatitis[J]. World J Emerg Surg, 2019, 14: 27. DOI: 10.1186/s13017-019-0247-0
[2]
SANDZÉN B, ROSENMVLLER M, HAAPAMÄKI MM, et al. First attack of acute pancreatitis in Sweden 1988-2003: Incidence, aetiological classification, procedures and mortality-a register study[J]. BMC Gastroenterol, 2009, 9: 18. DOI: 10.1186/1471-230X-9-18
[3]
ROBERTS SE, MORRISON-REES S, JOHN A, et al. The incidence and aetiology of acute pancreatitis across Europe[J]. Pancreatology, 2017, 17(2): 155-165. DOI: 10.1016/j.pan.2017.01.005
[4]
BANKS PA, BOLLEN TL, DERVENIS C, et al. Classification of acute pancreatitis-2012: Revision of the Atlanta classification and definitions by international consensus[J]. Gut, 2013, 62(1): 102-111. DOI: 10.1136/gutjnl-2012-302779
[5]
VLGER BV, GVL M, USLUKAYA Ö, et al. New hormones to predict the severity of gallstone-induced acute pancreatitis[J]. Turk J Gastroenterol, 2014, 25(6): 714-717. http://europepmc.org/abstract/med/25599787
[6]
SCHERER J, SINGH VP, PITCHUMONI CS, et al. Issues in hypertriglyceridemic pancreatitis: An update[J]. J Clin Gastroenterol, 2014, 48(3): 195-203. DOI: 10.1097/01.mcg.0000436438.60145.5a
[7]
GAO YJ, LI YQ, WANG Q, et al. Analysis of the clinical features of recurrent acute pancreatitis in China[J]. J Gastroenterol, 2006, 41(7): 681-685. DOI: 10.1007/s00535-006-1820-3
CLEGG A, YOUNG J, ILIFFE S, et al. Frailty in elderly people[J]. Lancet, 2013, 381(9868): 752-762. DOI: 10.1016/S0140-6736(12)62167-9
[10]
ZHU Y, PAN X, ZENG H, et al. A study on the etiology, severity, and mortality of 3260 patients with acute pancreatitis according to the Revised Atlanta Classification in Jiangxi, China over an 8-year period[J]. Pancreas, 2017, 46(4): 504-509. DOI: 10.1097/MPA.0000000000000776
[11]
QUERO G, COVINO M, OJETTI V, et al. Acute pancreatitis in oldest old: A 10-year retrospective analysis of patients referred to the emergency department of a large tertiary hospital[J]. Eur J Gastroenterol Hepatol, 2020, 32(2): 159-165. DOI: 10.1097/MEG.0000000000001570
[12]
Editoral Board of Chinese Journal of Digestion, Cooperation Group of Hepatobiliary Disease of Chinese Society of Gastroenterology. Consensus on diagnosis and treatment of chronic cholecystitis and gallstones in China (2018)[J]. J Clin Hepatol, 2019, 35(6): 1231-1236. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2019.06.011
TAI WP, ZHANG NW, ZHU B, et al. Clinical characteristics and diagnosis and treatment efficiency of acute pancreatitis in the elderly[J]. Chin J Mult Organ Dis Elderly, 2018, 17(1): 57-60. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-ZLQG201801015.htm
BARBEIRO DF, KOIKE MK, COELHO AM, et al. Intestinal barrier dysfunction and increased COX-2 gene expression in the gut of elderly rats with acute pancreatitis[J]. Pancreatology, 2016, 16(1): 52-56. DOI: 10.1016/j.pan.2015.10.012
[15]
CARVALHO JR, FERNANDES SR, SANTOS P, et al. Acute pancreatitis in the elderly: A cause for increased concern?[J]. Eur J Gastroenterol Hepatol, 2018, 30(3): 337-341. DOI: 10.1097/MEG.0000000000001028
[16]
MIN A, LI H, XIANG HP, et al. Comparison of three classification systems for acute pancreatitis[J]. Chin J Emerge Med, 2019, 28(5): 625-629. (in Chinese) DOI: 10.3760/cma.j.issn.1671-0282.2019.05.018
JIANG X, XU H, YAN YF, et al. Clinical and prognostic characteristics of alcoholic pancreatitis[J]. J Clin Hepatol, 2019, 35(11): 2528-2532. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2019.11.027
TANG YL, FANG CG, WU WW, et al. Analysis of high risk factors and predictive models of secondary pancreatic necrosis in acute biliary pancreatitis[J]. Trauma and Crit Medicine, 2020, 8(2): 104-106, 109.(in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-CSJB202002012.htm
LÖHR JM, PANIC N, VUJASINOVIC M, et al. The ageing pancreas: A systematic review of the evidence and analysis of the consequences[J]. J Intern Med, 2018, 283(5): 446-460. DOI: 10.1111/joim.12745
[20]
SHEN XZ, WU SD. Pathogenesis and progress of diagnosis and treatment of severe acute pancreatitis-associated kidney injury[J]. Chin J Dig, 2019, 39(5): 300-303. (in Chinese) DOI: 10.3760/cma.j.issn.0254-1432.2019.05.005
PATEL K, LI F, LUTHRA A, et al. Acute biliary pancreatitis is associated with adverse outcomes in the elderly: A propensity score-matched analysis[J]. J Clin Gastroenterol, 2019, 53(7): e291-e297. DOI: 10.1097/MCG.0000000000001108
MÁRTA K, LAZARESCU AM, FARKAS N, et al. Aging and comorbidities in acute pancreatitis I: A Meta-analysis and systematic review based on 194, 702 patients[J]. Front Physiol, 2019, 10: 328. DOI: 10.3389/fphys.2019.00328
HAN L, LIANG QS, XIE H, et al. Value of baseline IgM level in predicting the treatment response of primary biliary cholangitis[J]. J Clin Hepatol, 2022, 38(4): 815-820. DOI: 10.3969/j.issn.1001-5256.2022.04.015.
HAN L, LIANG QS, XIE H, et al. Value of baseline IgM level in predicting the treatment response of primary biliary cholangitis[J]. J Clin Hepatol, 2022, 38(4): 815-820. DOI: 10.3969/j.issn.1001-5256.2022.04.015.
下载:
DownLoad: